The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
The spectrum of genomic alterations in young adult non-small cell lung cancer (NSCLC).
Geoffrey R. Oxnard
Consultant or Advisory Role - Boehringer Ingelheim; Genentech
Jennifer C. Heng
No relevant relationships to disclose
Stacy L. Mach
No relevant relationships to disclose
Peter C. Lo
No relevant relationships to disclose
Mohit Butaney
No relevant relationships to disclose
David Michael Jackman
Consultant or Advisory Role - Foundation Medicine; Genentech; Infinity
Honoraria - Chugai Pharma
Pasi A. Janne
Consultant or Advisory Role - Abbott Laboratories; Boehringer Ingelheim; Chugai Pharma; Genentech; Pfizer (U); Roche; Sanofi
Other Remuneration - LabCorp